X

Trial Profile

Phase Ib Trial of Enzalutamide in Combination With Radiation Therapy and LHRH Agonist Therapy in the Management of Intermediate and High-Risk Prostate Cancer

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 07 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Enzalutamide (Primary) ; Goserelin; Leuprorelin; Leuprorelin
Indications Adenocarcinoma; Prostate cancer
Focus Adverse reactions

Most Recent Events

27 Sep 2019 Planned End Date changed from 1 Jan 2020 to 1 Jan 2040.
09 Apr 2019 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
25 Jul 2017 Planned End Date changed from 1 Dec 2018 to 1 Jan 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com